Literature DB >> 12893532

Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review).

Satinder S Rawat1, Mathias Viard, Stephen A Gallo, Alan Rein, Robert Blumenthal, Anu Puri.   

Abstract

Enveloped animal viruses infect host cells by fusion of viral and target membranes. This crucial fusion event occurs either with the plasma membrane of the host cells at the physiological pH or with the endosomal membranes at low pH and is triggered by specific glycoproteins in the virus envelope. Both lipids and proteins play critical and co-operative roles in the fusion process. Interactions of viral proteins with their receptors direct which membranes fuse and viral fusion proteins then drive the process. These fusion proteins operate on lipid assemblies, whose physical and mechanical properties are equally important to the proper functioning of the process. Lipids contribute to the viral fusion process by virtue of their distinct chemical structure, composition and/or their preferred partitioning into specific microdomains in the plasma membrane called 'rafts'. An involvement of lipid rafts in viral entry and membrane fusion has been examined recently. However, the mechanism(s) by which lipids as dynamic raft components control viral envelope-glycoprotein-triggered fusion is not clear. This paper will review literature findings on the contribution of the two raft-associated lipids, cholesterol and sphingolipids in viral entry.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893532     DOI: 10.1080/0968768031000104944

Source DB:  PubMed          Journal:  Mol Membr Biol        ISSN: 0968-7688            Impact factor:   2.857


  42 in total

1.  Parvovirus infection of cells by using variants of the feline transferrin receptor altering clathrin-mediated endocytosis, membrane domain localization, and capsid-binding domains.

Authors:  Karsten Hueffer; Laura M Palermo; Colin R Parrish
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Enhancement of enveloped virus entry by phosphatidylserine.

Authors:  David A Coil; A Dusty Miller
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus.

Authors:  Matthew I Bonaparte; Antony S Dimitrov; Katharine N Bossart; Gary Crameri; Bruce A Mungall; Kimberly A Bishop; Vidita Choudhry; Dimiter S Dimitrov; Lin-Fa Wang; Bryan T Eaton; Christopher C Broder
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-05       Impact factor: 11.205

4.  Murine coronavirus requires lipid rafts for virus entry and cell-cell fusion but not for virus release.

Authors:  Keum S Choi; Hideki Aizaki; Michael M C Lai
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies.

Authors:  Birke Bartosch; Géraldine Verney; Marlène Dreux; Peggy Donot; Yoann Morice; François Penin; Jean-Michel Pawlotsky; Dimitri Lavillette; Francois-Loïc Cosset
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Cubic phases in phosphatidylcholine-cholesterol mixtures: cholesterol as membrane "fusogen".

Authors:  Boris G Tenchov; Robert C MacDonald; David P Siegel
Journal:  Biophys J       Date:  2006-07-07       Impact factor: 4.033

7.  Ceramide, a target for antiretroviral therapy.

Authors:  Catherine M Finnegan; Satinder S Rawat; Anu Puri; Ji Ming Wang; Francis W Ruscetti; Robert Blumenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-15       Impact factor: 11.205

8.  Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.

Authors:  Ana M Chamoun-Emanuelli; Eve-Isabelle Pecheur; Rudo L Simeon; Da Huang; Paul S Cremer; Zhilei Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

9.  A multiscale model for virus capsid dynamics.

Authors:  Changjun Chen; Rishu Saxena; Guo-Wei Wei
Journal:  Int J Biomed Imaging       Date:  2010-03-09

10.  Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.

Authors:  Marlène Dreux; Viet Loan Dao Thi; Judith Fresquet; Maryse Guérin; Zélie Julia; Géraldine Verney; David Durantel; Fabien Zoulim; Dimitri Lavillette; François-Loïc Cosset; Birke Bartosch
Journal:  PLoS Pathog       Date:  2009-02-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.